BSE filing, NSE: HINDCOMPOS. Summary written from the filing by ALFA Finder's alert engine.
Hindustan Composites Ltd: key numbers
- Share price
- ₹372.00
- Market cap
- ₹549.4 Cr
- Revenue (annual)
- ₹375.0 Cr
- Net profit (annual)
- ₹31.11 Cr
- P/E (TTM)
- 17.0×Sector 31.4×
- Promoter holding
- 74.98%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Hindustan Composites Ltd
All →Hindustan Composites Board Meeting Date
Hindustan Composites will hold a board meeting on November 5, 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. The trading window stays closed until November 7, 2026.
Hindustan Composites Dividend
Hindustan Composites declared a special interim dividend of Rs. 21 per share for the financial year 2026-27. The record date is set for October 16, 2026.
Hindustan Composites Board Meeting Date
Hindustan Composites will hold a board meeting on October 12, 2026, to consider declaring a special interim dividend for the financial year 2026-27.
Hindustan Composites Other Announcement
Hindustan Composites Ltd appointed M/s. R M Mimani & Associates LLP as Secretarial Auditors for five years, commencing from the 2026-27 financial year.
- Execution
- 5 years
Hindustan Composites Annual General Meeting
Hindustan Composites Ltd held its 62nd Annual General Meeting, approving financial statements, dividends, and director appointments. The meeting was conducted via video conferencing.
Hindustan Composites Other Announcement
Hindustan Composites informed shareholders that letters providing access to the Annual Report and 62nd AGM Notice have been dispatched to those with unregistered email addresses.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.